Find Research Outputs

Search results

• 2017

  Treatment of Adult mdx Mice with Phosphorodiamidate Morpholino Oligomer Restores Cardiac Mitochondrial Energetics and Prevents the Dystrophic Cardiomyopathy

  Viola, H. M., Johnstone, V. P. A., Adams, A. M., Fletcher, S. & Hool, L. C., 3 Feb 2017, In : Biophysical Journal. 112, 3, p. 245A-245A 1 p.

  Research output: Contribution to journal › Abstract/Meeting Abstract
• 2019

  Altered myogenesis and premature senescence underlie human TRIM32-related myopathy

  Servián-Morilla, E., Cabrera-Serrano, M., Rivas-Infante, E., Carvajal, A., Lamont, P. J., Pelayo-Negro, A. L., Ravenscroft, G., Junckerstorff, R., Dyke, J. M., Fletcher, S., Adams, A. M., Mavillard, F., Fernández-García, M. A., Nieto-González, J. L., Laing, N. G. & Paradas, C., 1 Mar 2019, In : Acta Neuropathologica Communications. 7, 1, 1 p.

  Research output: Contribution to journal › Article

  Open Access

  • Muscle Development
  • Muscular Diseases
  • Bardet-Biedl Syndrome
  • Muscles
  • Limb-girdle muscular dystrophy type 2H
  6 Citations (Scopus)
• 2014

  Rare Disease Research Roadmap: Navigating the bioinformatics and translational challenges for improved patient health outcomes

  Bellgard, M. I., Sleeman, M. W., Guerrero, F. D., Fletcher, S., Baynam, G., Goldblatt, J., Rubinstein, Y. R., Bell, C., Groft, S. C., Barrero, R., Bittles, A. H., Wilton, S., Mason, C. E. & Weeramanthri, T. S., 2014, In : Health Policy And Technology. 3, 4, p. 325-335

  Research output: Contribution to journal › Article

  • Bioinformatics
  • Rare Diseases
  • Computational Biology
  • Health
  • Registries
  7 Citations (Scopus)

• Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene

  Greer, K. L., Lochmueller, H., Flanigan, K., Fletcher, S. & Wilton, S. D., 18 Mar 2014, In : Molecular Therapy-Nucleic Acids. 3, p. 1-7 7 p., 155.

  Research output: Contribution to journal › Article

  Open Access
  19 Citations (Scopus)
• 2012

  Targeted exon skipping to address "leaky" mutations in the dystrophin gene

  Fletcher, S., Adkin, C., Meloni, P., Wong, B., Muntoni, F., Kole, R., Fragall, C., Greer, K., Johnsen, R. & Wilton, S., 2012, In : Molecular Therapy-Nucleic Acids. 1, p. e48

  Research output: Contribution to journal › Article

  Open Access
  15 Citations (Scopus)
• 2014

  Antisense oligonucleotide induction of progerin in human myogenic cells

  Luo, Y., Mitrpant, C., Adams, A., Johnsen, R., Fletcher, S., Mastaglia, F. & Wilton, S., 2014, In : PLoS One. 9, 6, p. 9pp

  Research output: Contribution to journal › Article

  Open Access

  • Lamin Type A
  • Antisense Oligonucleotides
  • Oligonucleotides
  • Exons
  • Progeria
  8 Citations (Scopus)
• 2019

  Breakpoint junction features of seven DMD deletion mutations

  Keegan, N. P., Wilton, S. D. & Fletcher, S., 1 Dec 2019, In : Human Genome Variation. 6, 1, 39.

  Research output: Contribution to journal › Article

  Open Access

  • Duchenne Muscular Dystrophy
  • Sequence Deletion
  • Bioinformatics
  • Muscle
  • Genes

• ANTISENSE OLIGONUCLEOTIDES TO IMPROVE CFTR FUNCTION FOR PEOPLE WITH THE INTRON 9 5T POLYMORPHISM

  AREST CF, Oct 2019, In : Pediatric Pulmonology. 54, p. S217-S218 2 p.

  Research output: Contribution to journal › Abstract/Meeting Abstract

• Reduction of integrin alpha 4 activity through splice modulating antisense oligonucleotides

  Aung-Htut, M. T., Comerford, I., Johnsen, R., Foyle, K., Fletcher, S. & Wilton, S. D., 10 Sep 2019, In : Scientific Reports. 9, 1, 1 p.

  Research output: Contribution to journal › Article

  Open Access

  • Integrin alpha Chains
  • Antisense Oligonucleotides
  • RNA Precursors
  • Exons
  • Disease Progression
  4 Citations (Scopus)
• 2015

  Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient

  Greer, K., Mizzi, K., Rice, E., Kuster, L., Barrero, R. A., Bellgard, M. I., Lynch, B. J., Foley, A. R., O Rathallaigh, E., Wilton, S. & Fletcher, S., 2015, In : Molecular Genetics and Genomics. 3, 4, p. 320-326

  Research output: Contribution to journal › Article

  Open Access
  13 Citations (Scopus)
• 2018

  RESCUE OF CFTR FUNCTION IMPAIRED BY MUTATIONS IN EXON 15 IN CHILDREN WITH CYSTIC FIBROSIS

  AREST CF & WAERP, Sep 2018, In : Pediatric Pulmonology. 53, p. 224-224 1 p.

  Research output: Contribution to journal › Abstract/Meeting Abstract

  15 Citations (Scopus)
• 2014

  Impaired functional communication between the L-type calcium channel and mitochondria contributes to metabolic inhibition in the mdx heart

  Viola, H., Adams, A., Davies, S., Fletcher, S., Filipovska, A. & Hool, L., Jul 2014, In : Proceedings of the National Academy of Sciences of the United States of America. 111, 28, p. E2905-E2914

  Research output: Contribution to journal › Article

  Open Access

  • L-Type Calcium Channels
  • Dystrophin
  • Voltage-Dependent Anion Channels
  • Duchenne Muscular Dystrophy
  • Mitochondria
  29 Citations (Scopus)
• 2018

  A platform for discovery of functional cell-penetrating peptides for efficient multi-cargo intracellular delivery

  Hoffmann, K., Milech, N., Juraja, S. M., Cunningham, P. T., Stone, S. R., Francis, R. W., Anastasas, M., Hall, C. M., Heinrich, T., Bogdawa, H. M., Winslow, S., Scobie, M. N., Dewhurst, R. E., Florez, L., Ong, F., Kerfoot, M., Champain, D., Adams, A. M., Fletcher, S., Viola, H. M. & 10 others, Hool, L. C., Connor, T., Longville, B. A. C., Tan, Y. F., Kroeger, K., Morath, V., Weiss, G. A., Skerra, A., Hopkins, R. M. & Watt, P. M., 1 Dec 2018, In : Scientific Reports. 8, 1, 12538.

  Research output: Contribution to journal › Article

  Open Access

  • Cell-Penetrating Peptides
  • Cytoplasm
  • Peptide Nucleic Acids
  • Bacterial Genomes
  • Cell Engineering
  24 Citations (Scopus)

• Design of a framework for the deployment of collaborative independent rare disease-centric registries: Gaucher disease registry model

  Bellgard, M. I., Napier, K. R., Bittles, A. H., Szer, J., Fletcher, S., Zeps, N., Hunter, A. A. & Goldblatt, J., Feb 2018, In : Blood Cells, Molecules, and Diseases. 68, p. 232-238

  Research output: Contribution to journal › Article

  Open Access

  • Gaucher Disease
  • Rare Diseases
  • Registries
  • Orphan Drug Production
  • Sustainable Development
  12 Citations (Scopus)

• Precision Medicine through Antisense Oligonucleotide-Mediated Exon Skipping

  Li, D., Mastaglia, F. L., Fletcher, S. & Wilton, S. D., 1 Nov 2018, In : Trends in Pharmacological Sciences. 39, 11, p. 982-994 13 p.

  Research output: Contribution to journal › Review article

  • Antisense Oligonucleotides
  • Precision Medicine
  • Medicine
  • Exons
  • Duchenne Muscular Dystrophy
  16 Citations (Scopus)
• 2012

  Multiple exon skipping strategies to by-pass dystrophin mutations

  Adkin, C., Meloni, P., Fletcher, S., Adams, A., Muntoni, F., Wong, B. & Wilton, S., 2012, In : Neuromuscular Disorders. 22, 4, p. 297-305

  Research output: Contribution to journal › Article

  Open Access
  13 Citations (Scopus)
• 2018

  Skipping of Duplicated Dystrophin Exons: In Vitro Induction and Assessment

  Greer, K., Fletcher, S. & Wilton, S. D., 1 Jan 2018, Methods in Molecular Biology. Yokota, T. & Maruyama, R. (eds.). USA: Humana Press, p. 219-228 10 p. (Methods in Molecular Biology; vol. 1828).

  Research output: Chapter in Book/Conference paper › Chapter

  • Dystrophin
  • Exons
  • In Vitro Techniques
  • Reading Frames
  • Polymerase Chain Reaction
  1 Citation (Scopus)
• 2019

  Removal of the polyglutamine repeat of ataxin-3 by redirecting pre-mrna processing

  McIntosh, C. S., Aung-Htut, M. T., Fletcher, S. & Wilton, S. D., 1 Nov 2019, In : International Journal of Molecular Sciences. 20, 21, 5434.

  Research output: Contribution to journal › Article

  Open Access

  • ataxia
  • Ataxin-3
  • Machado-Joseph Disease
  • Oligomers
  • Morpholinos
  1 Citation (Scopus)
• 2017

  Comprehending the Health informatics Spectrum: Grappling with System Entropy and Advancing Quality Clinical Research

  Bellgard, M. I., Chartres, N., Watts, G. F., Wilton, S., Fletcher, S., Hunter, A. & Snelling, T., 14 Sep 2017, In : Frontiers in Public Health. 5, 5 p., 224.

  Research output: Contribution to journal › Editorial

  Open Access
• 2019

  Antisense-mediated splice intervention to treat human disease: the odyssey continues

  Pitout, I., Flynn, L. L., Wilton, S. D. & Fletcher, S., 22 May 2019, In : F1000Research. 8, 710.

  Research output: Contribution to journal › Review article

  Open Access

  • Oligonucleotides
  • Nucleic Acids
  • Biomolecules
  • Degradation
  • Physicochemical properties
  4 Citations (Scopus)

• ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?

  Mejzini, R., Flynn, L. L., Pitout, I. L., Fletcher, S., Wilton, S. D. & Akkari, P. A., 6 Dec 2019, In : Frontiers in Neuroscience. 13, 1310.

  Research output: Contribution to journal › Review article

  Open Access

  • Amyotrophic Lateral Sclerosis
  • Genes
  • Therapeutics
  • Direction compound
  • Research Personnel
  45 Citations (Scopus)
• 2012

  Optimizing splice-switching oligomer sequences using 2'-o-methyl phosphorothioate chemistry

  Adkin, C., Fletcher, S. & Wilton, S., 2012, Exon Skipping: Methods and Protocols. Aartsma-Rus, A. (ed.). United States: Humana Press, Vol. 867. p. 169-188 (Methods in Molecular Biology).

  Research output: Chapter in Book/Conference paper › Chapter
  3 Citations (Scopus)
• 2011

  Mismatched single stranded antisense oligonucleotides can induce efficient dystrophin splice switching

  Fragall, C., Adams, A., Johnsen, R., Kole, R., Fletcher, S. & Wilton, S., 2011, In : BMC Medical Genetics. 12, p. 141

  Research output: Contribution to journal › Article

  Open Access
  6 Citations (Scopus)

• RNA splicing manipulation: Strategies to modify gene expression for a variety of therapeutic outcomes

  Wilton, S. & Fletcher, S., 2011, In : Current gene therapy. 11, 4, p. 259-275

  Research output: Contribution to journal › Article
  14 Citations (Scopus)
• 2019

  Consequences of Making the Inactive Active Through Changes in Antisense Oligonucleotide Chemistries

  Zaw, K., Greer, K., Aung-Htut, M. T., Mitrpant, C., Veedu, R. N., Fletcher, S. & Wilton, S. D., 20 Dec 2019, In : Frontiers in Genetics. 10, 1249.

  Research output: Contribution to journal › Article

  Open Access

  • Antisense Oligonucleotides
  • Exons
  • locked nucleic acid
  • RNA Splice Sites
  • Dystrophin
  1 Citation (Scopus)
• 2018

  The potential of antisense oligonucleotide therapies for inherited childhood lung diseases

  Martinovich, K. M., Shaw, N., Kicic, A., Fletcher, S., Schultz, A., Wilton, S. D. & Stick, S., 2018, In : Molecular and Cellular Pediatrics. 5, 3.

  Research output: Contribution to journal › Review article

  Open Access

  • Antisense Oligonucleotides
  • Lung Diseases
  • eteplirsen
  • RNA Precursors
  • nusinersen
• 2019

  Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides

  Aung-Htut, M. T., McIntosh, C. S., Ham, K. A., Pitout, I. L., Flynn, L. L., Greer, K., Fletcher, S. & Wilton, S. D., 11 Oct 2019, In : International Journal of Molecular Sciences. 20, 20

  Research output: Contribution to journal › Article

  Open Access

  • Oligonucleotides
  • Messenger RNA
  • oligonucleotides
  • splicing
  • Antisense Oligonucleotides
  4 Citations (Scopus)
• 2017

  Translational development of splice-modifying antisense oligomers

  Fletcher, S., Bellgard, M., Price, L., Akkari, A. & Wilton, S., 2 Jan 2017, In : Expert Opinion on Biological Therapy. 17, 1, p. 15-30 16 p.

  Research output: Contribution to journal › Review article

  • Oligomers
  • Spinal Muscular Atrophy
  • Exons
  • Duchenne Muscular Dystrophy
  • Interdisciplinary Research
  15 Citations (Scopus)
• 2011

  Gene therapy: Therapeutic applications and relevance to pathology

  Both, G., Alexander, I., Fletcher, S., Nicolson, T. J., Rasko, J. E. J., Wilton, S. & Symonds, G., 2011, In : Pathology. 43, 6, p. 642-656

  Research output: Contribution to journal › Article
  12 Citations (Scopus)

• Molecular diagnosis of duchenne muscular dystrophy: Past, present and future in relation to implementing therapies

  Laing, N., Davis, M. R., Bayley, K., Fletcher, S. & Wilton, S., 2011, In : Clinical Biochemist Reviews. 32, 3, p. 129-134

  Research output: Contribution to journal › Article

  28 Citations (Scopus)
• 2016

  Deletion of dystrophin in-frame exon 5 leads to a severe phenotype: Guidance for exon skipping strategies

  Toh, Z. Y. C., Aung-Htut, M. T., Pinniger, G., Adams, A., Krishnaswarmy, S., Wong, B. L., Fletcher, S. & Wilton, S., 8 Jan 2016, In : PLoS One. 11, 1, p. 1-17 e0145620.

  Research output: Contribution to journal › Article

  Open Access

  File

  • Dystrophin
  • Exons
  • Phenotype
  • Duchenne Muscular Dystrophy
  • Protein Isoforms
  14 Citations (Scopus)

  399 Downloads (Pure)
• 2012

  Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements

  Barrett, L., Fletcher, S. & Wilton, S., 2012, In : Cellular and Molecular Life Sciences. 69, 21, p. 3613-3634

  Research output: Contribution to journal › Article

  Open Access
  288 Citations (Scopus)